Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
Conditions
Esophageal Cancer · Surgery · Neoadjuvant Treatment · Survival
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou, Henan, China
Contact: Principal Investigator (Yan Zheng, PhD)
Study leads
Yan Zheng, PhD, MD
Principal Investigator
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university